There are errors in Table 1 on page 294 of the print version of the article. In the “UK cases” column, the percentage of patients <50 years old should be 42, not 41. In the “US cases” column, the number of patients <70 years old should be 28, not 15; the percentage of patients with cerebral vein thrombosis (CVT) should be 68, not 80; the percentage of patients with intracerebral hemorrhage (ICH) should be 36, not 52; and the percentage of patients who died should be 11, not 20. The errors were corrected in the online version of the article before publication.
. 2023 Feb 16;141(7):808. doi: 10.1182/blood.2022017479
Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Blood. 2021;138(4):293-298.
Issue date 2023 Feb 16.
© 2023 by The American Society of Hematology.
PMCID: PMC9933574 PMID: 36795442
This corrects the article "MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML" in volume 132 on page 1526.
This corrects the article "Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know" in volume 138 on page 293.
